Clinical Trials Browser

Glioma × Immunotherapy, Adoptive × 1 year × Clear all

NCT06482905 2026-03-24

Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.

Phase 1 Recruiting

Glioma